Press Releases

All Releases
View Summary LAL Deficiency Disease Review Published in Atherosclerosis
Apr 21, 2014
PDF 27.3 KB
View Summary Synageva Biopharma Announces Pricing of Public Offering of Common Stock
Mar 5, 2014
PDF 23.1 KB
View Summary Synageva Biopharma™ Announces a 2.00 Million Share Proposed Public Offering of Its Common Stock
Mar 4, 2014
PDF 22.8 KB
View Summary Synageva BioPharma™ Issued U.S. Patent for Treatment of LAL Deficiency
Mar 4, 2014
PDF 26.4 KB
View Summary Synageva BioPharma™ Reports 2013 Full Year Financial Results
Mar 3, 2014
PDF 35.8 KB
View Summary Synageva BioPharma™ Joins NORD, EURORDIS, and The Global Genes Project in Support of Rare Disease Day 2014
Feb 28, 2014
PDF 30.3 KB
View Summary Synageva BioPharma™ to Present at the Cowen and Company Health Care Conference
Feb 21, 2014
PDF 21.9 KB
View Summary Synageva BioPharma™ to Host 2013 Fourth Quarter and Full Year Financial Results Conference Call on March 3
Feb 18, 2014
PDF 22.0 KB
View Summary Synageva BioPharma™ Highlights Sebelipase Alfa and LAL Deficiency Data at the Lysosomal Disease Network (LDN) WORLD Symposium™
Feb 13, 2014
PDF 31.4 KB
View Summary Synageva BioPharma™ Highlights SBC-103 Data at the Lysosomal Disease Network (LDN) WORLD Symposium™
Feb 12, 2014
PDF 28.4 KB
View Summary Synageva BioPharma™ Announces Data Presentations at the 10th Annual Lysosomal Disease Network (LDN) World Symposium
Jan 29, 2014
PDF 28.4 KB
View Summary Synageva Biopharma™ Provides Clinical Trial Updates with Sebelipase ALFA in LAL Deficiency
Jan 6, 2014
PDF 28.2 KB
View Summary Synageva BioPharma™ to Present at the 32nd Annual J.P. Morgan Healthcare Conference
Jan 2, 2014
PDF 27.4 KB
View Summary Synageva BioPharma™ to Present at Upcoming Investor Conference
Dec 4, 2013
PDF 27.4 KB
View Summary Synageva BioPharma™ Completes Target Enrollment in Phase 3 ARISE Trial with Sebelipase Alfa in Children and Adults with LAL Deficiency
Dec 2, 2013
PDF 27.6 KB
View Summary Synageva BioPharma™ to Present at the Jefferies 2013 Global Healthcare Conference
Nov 12, 2013
PDF 27.2 KB
View Summary Synageva BioPharma™ Reports Third Quarter 2013 Financial Results
Oct 29, 2013
PDF 35.4 KB
View Summary Synageva BioPharma™ Highlights Data at the NASPGHAN Meeting
Oct 11, 2013
PDF 29.8 KB
View Summary Synageva BioPharma Announces Closing of Public Offering and Exercise of Option to Purchase Additional Shares
Sep 30, 2013
PDF 28.5 KB
View Summary Synageva BioPharma Announces Pricing of Public Offering of Common Stock
Sep 24, 2013
PDF 22.4 KB
Showing 1-20 of 101 Page: 1 2 3 4 5 6  Next 20